Eif2b5tm2.1Sidr
Targeted Allele Detail
|
Symbol: |
Eif2b5tm2.1Sidr |
Name: |
eukaryotic translation initiation factor 2B, subunit 5 epsilon; targeted mutation 2.1, Carmela Sidrauski |
MGI ID: |
MGI:6416109 |
Synonyms: |
Eif2b5R132H |
Gene: |
Eif2b5 Location: Chr16:20317567-20328073 bp, + strand Genetic Position: Chr16, 12.45 cM
|
Alliance: |
Eif2b5tm2.1Sidr page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:278928
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
C57BL/6J
|
|
Allele Type: |
|
Targeted (Conditional ready, Humanized sequence) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: Residue arginine 132 was changed to histamine, loxP sites were inserted flanking some of the exons including the mutation, and a FRT-flanked neomycin resistance cassette was inserted upstream of the mutation. The neomycin resistance cassette was removed via flp-mediated recombination. The R132H mutation corresponds to the vanishing white matter causing human R136H allele.
(J:278928)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Eif2b5 Mutation: |
31 strains or lines available
|
|
Original: |
J:278928 Wong YL, et al., eIF2B activator prevents neurological defects caused by a chronic integrated stress response. Elife. 2019 Jan 9;8:e42940 |
All: |
1 reference(s) |
|